Avanza Fonder Ab Pacific Biosciences Of California, Inc. Transaction History
Avanza Fonder Ab
- $3.37 Trillion
- Q4 2024
A detailed history of Avanza Fonder Ab transactions in Pacific Biosciences Of California, Inc. stock. As of the latest transaction made, Avanza Fonder Ab holds 76,408 shares of PACB stock, worth $97,802. This represents 0.0% of its overall portfolio holdings.
Number of Shares
76,408Holding current value
$97,802% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PACB
# of Institutions
259Shares Held
256MCall Options Held
3.05MPut Options Held
1.71M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl36MShares$46.1 Million0.58% of portfolio
-
Black Rock Inc. New York, NY23.6MShares$30.2 Million0.0% of portfolio
-
Madrone Advisors, LLC Menlo Park, CA23.4MShares$29.9 Million8.16% of portfolio
-
Edmond De Rothschild Holding S.A. Chambesy, V821.3MShares$27.3 Million0.68% of portfolio
-
Softbank Group Corp Minato Ku Tokyo, M020.5MShares$26.2 Million0.17% of portfolio
About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
- Ticker PACB
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 224,840,992
- Market Cap $288M
- Description
- Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...